Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

1920px-hiv-budding-color

Researchers launch Phase 1 trial of HIV vaccine

October 18, 2018 Research and Development AIDS, HIV, Vaccine, infection, resdearch

Researchers working with the non-profit organisation the International AIDS Vaccine Initiative (IAVI) have announced the launch of a Phase I …
News

Samsung and Bioepis launch third Humira biosimilar in Europe

October 17, 2018 Research and Development, Sales and Marketing Amgen, Biogen, Humira, Imraldi, Samusng Bioepis, pharma

Hot on the heels of Amgen, Samsung Bioepis and Biogen have announced the launch of their own biosimilar version of …
News
roche_dark_0

Roche signs $1 billion deal with cell therapy firm SQZ biotech

October 17, 2018 Research and Development Roche, SQZ, collaboration, deal, oncology

The Massachusetts-based cell therapy company SQZ Biotech, has announced the expansion of its collaboration with Swiss pharma giant Roche, in …
News

Fewer patents being filed for novel infectious diseases and AMR diagnostic technologies; US leads, UK follows

October 17, 2018 Research and Development AMR, IP, intellectual property, patents

Fewer patents are being filed for point-of-care diagnostic technologies aimed at tackling infectious diseases and antimicrobial resistance (AMR), according to …
News

FDA approves Pfizer’s Talzenna for breast cancer alongside tool to identify eligible patients

October 17, 2018 Research and Development, Sales and Marketing Cancer, FDA, Pfizer, Talzenna, breast cancer, pharma

Pfizer’s Talzenna (talazoparib) has secured FDA approval, it has emerged. The poly (ADP-ribose) polymerase (PARP) inhibitor is now set to …
News
opioid_pills

Prescription painkillers reclassified amid addiction concerns

October 17, 2018 Research and Development UK, addiction, classification, painkillers, policy

Two commonly prescribed painkillers are set to be put under tighter controls in the United Kingdom after a number of …
News
merckwindow_web

MSD and Samsung Bioepis terminate development of Lantus biosimilar for diabetes

October 15, 2018 Research and Development, Sales and Marketing Lantus, MSD, Samsung Bioepis, Sanofi, biosimilar, diabetes, pharma

MSD has reportedly terminated a previous agreement with Samsung Bioepis which would have seen them collaborate on a biosimilar version …
News
ai_robot

AI, big data: Making a case for faster drug discovery

October 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Big Data, feature, healthcare, research

They’re two of the biggest buzzwords getting professionals excited across pharma – Anjali Shukla explores the ways in which AI …
Feature

BMS’ Opdivo fails to improve overall survival in small-cell lung cancer

October 15, 2018 Research and Development, Sales and Marketing BMS< Opdivo, Bristol-Myers Squibb, Cancer, lung cancer, pharma

Bristol-Myers Squibb’s Opdivo (nivolumab) failed to deliver on its primary endpoint in a Phase 3 study in small-cell lung cancer, …
News
novo_flag

Novo Nordisk’s Fiasp shows strong blood sugar control in under-18 type 1 diabetes patients

October 12, 2018 Medical Communications, Research and Development Fiasp, Novo Nordisk, Type 1 diabetes, diabetes, pharma

New data unveiled by Novo Nordisk has shown that its insulin injection Fiasp (fast-acting insulin aspart) could provide a better …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, biosimilars. GSK, manufacturing, pharma, top 10

Politics played a big role in pharma this week after Trump introduced legislation aimed at reducing the price of drugs. …
News

Living with Langerhans Cell Histiocytosis

October 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Langerhans Cell Histiocytosis, feature. pharma, patient experience, rare diseae

Affected as a young child by a rare disease which targets just one in 200,000 and led to neurodegeneration throughout …
Feature
roche__tree

Roche’s Ocrevus shows earlier, better outcomes in primary progressive and relapsing MS

October 11, 2018 Research and Development Ocrevus, Roche, multiple sclerosis, pharma

Roche has unveiled new five-year data from three Phase 3 open-label extension studies investigating the efficacy of Ocrevus (ocrelizumab) in …
News
38254130862_0f3fa01db3_z

New US trade policy may limit foreign investment into biotechs

October 11, 2018 Research and Development CIFUS, Trump, america, biotech, capital, foreign investment

The US Trump Administration have issued new rules, which will put foreign investment into companies involved in the development and …
News

Sequiris invest £40m into expansion of Liverpool plant creating 100 new jobs

October 11, 2018 Manufacturing and Production, Research and Development Jobs, Vaccine, investment, liverpool

The Liverpool-based vaccine-maker Sequiris is investing £40 million into the expansion of its operations in the Speke area of Liverpool. …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026